ABBOTT LABORATORIES — Director's Dealing 2014

Feb 25, 2014

Page 1 of 1

SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average burden hours per 0.5 response:

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Check this box if no longer subject to				Estimated average burden
Section 16. Form 4 or Form 5 obligations may continue._See_Instruction 1(b).		Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940		hours per response: 0.5
1. Name and Address of Reporting Person* Warmuth Michael J		2. Issuer NameandTicker or Trading Symbol ABBOTT LABORATORIES[ABT]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner
(Last) (First) 100 ABBOTT PARK ROAD	(Middle)	3. Date of Earliest Transaction (Month/Day/Year) 02/21/2014	X	Officer (give title below) Other (specify below) Executive Vice President
		4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable
(Street)			Line)
ABBOTT PARK IL	60064-6400		X	Form filed by One Reporting Person Form filed by More than One Reporting
				Person
(City) (State)	(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security	1. Title of Security	(Instr. 3)			2. Transaction Date 2A. Deemed Execution Date,	2. Transaction Date 2A. Deemed Execution Date,	2. Transaction Date 2A. Deemed Execution Date,	2. Transaction Date 2A. Deemed Execution Date,	3. Transaction	3. Transaction	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and	5. Amount Securities	of	6. Ownership Form: Direct	6. Ownership Form: Direct	7. Nature of Indirect
					(Month/Day/Year) if any				Code	(Instr.	5)		Beneficially		(D) or Indirect		Beneficial
							(Month/Day/Year)		8)				Owned Following		(I) (Instr. 4)		Ownership
													Reported				(Instr. 4)
									Code	V	Amount (A) or (D) Price		Transaction(s) (Instr. 3 and 4)
			Table	II - Derivative Securities Acquired, Disposed of, or								Beneficially Owned
				(e.g., puts, calls,			warrants, options, convertible					securities)
1. Title of	2.		3. Transaction	3A. Deemed	4.		5. Number of	6. Date	Exercisable and			7. Title and Amount of	8. Price of	9. Number		10.	11. Nature
Derivative	Conversion		Date	Execution Date,	Transaction		Derivative	Expiration Date				Securities Underlying	Derivative	of		Ownership	of Indirect
Security (Instr. 3)	or	Exercise	(Month/Day/Year)	if any	Code	(Instr.	Securities	(Month/Day/Year)				Derivative Security	Security	derivative		Form:	Beneficial
	Price of			(Month/Day/Year)	8)		Acquired (A)					(Instr. 3 and 4)	(Instr. 5)	Securities		Direct (D)	Ownership
	Derivative						or Disposed							Beneficially		or Indirect	(Instr. 4)
	Security						of (D) (Instr. 3,							Owned		(I) (Instr. 4)
							4 and 5)							Following
														Reported
												Amount or		Transaction
								Date		Expiration		Number of		(s) (Instr. 4)
					Code	V	(A) (D)	Exercisable		Date		Title Shares
Option (right to buy) (1)		$39.12	02/21/2014		A		107,793	02/21/2015		02/20/2024		Common shares 107,793	$0	107,793		D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,931 on 2/21/2015, 35,931 on 2/21/2016 and 35,931 on 2/21/2017.

John A. Berry, by power of attorney for Michael J. 02/25/2014 Warmuth

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

• ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

2/25/2014